VORAXAZE: payments to doctors
Payments that named VORAXAZE as the associated drug or biological, reported under the Sunshine Act for program years 2019–2025.
- Total reported
- $2.4M
- Providers
- 634
- Transactions
- 1,613
- Average per transaction
- $1,499
The per-transaction average — $1,499 — is the number that tells you what kind of spending this is. A few dollars means meals at product presentations, reported by the thousand. Hundreds or thousands means consulting, speaking or royalty arrangements with a much smaller group of physicians. Across all 634 providers the average total is $3,813, but that average hides a very steep distribution.
Companies reporting these payments
| Company | Total reported | Share |
|---|---|---|
| BTG International, Inc. | $2,206,943 | 91.3% |
| BTG International Inc. | $194,834 | 8.1% |
| Biocompatibles, Inc. | $15,576 | 0.6% |